cancer with
locoregional relapse in 40% to 60%. The frequency of relapses makes regional
radiotherapy an attractive possibility for adjuvant therapy. The survival
benefit of adjuvant chemoradiation over surgery alone was first established by
the US Intergroup 0116 study.
Between January
2010 and December 2014, 48 patients with localized gastric adenocarcinoma,
managed at radiotherapy
department of the national institut of oncology, they underwent adjuvant
chemoradiation according the classical MacDonald regimen.
This series
consisted of non-metastatic patients, 68.8% (33) males with a mean age 51
years. 20.8% (10) of patients had relapses (all distant relapse). 22 (45.8%)
patients died, only 8(16.6%) patients were lost to follow up.
No comments:
Post a Comment